arrow
S

Samuel J. P. Malkin

ossian health economics and communications
H指数:15
被引数:533

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW

每周一次的司美格鲁肽与安慰剂用于治疗丹麦2型糖尿病和慢性肾脏病的比较:一项基于FLOW研究的长期成本效益分析

2025-12-200
OAAI
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes
2024-09-160
OAAI